Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Dermatology
Published in: BMC Dermatology 1/2013

Open Access 01-12-2013 | Study protocol

Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care

Authors: Annett Körner, Martin Drapeau, Brett D Thombs, Zeev Rosberger, Beatrice Wang, Manish Khanna, Alan Spatz, Adina Coroiu, Rosalind Garland, Gerald Batist

Published in: BMC Dermatology | Issue 1/2013

Login to get access

Abstract

Background

Melanoma is the fastest growing tumor of the skin, which disproportionately affects younger and middle-aged adults. As melanomas are visible, recognizable, and highly curable while in early stages, early diagnosis is one of the most effective measures to decrease melanoma-related mortality. Skin self-examination results in earlier detection and removal of the melanoma. Due to the elevated risk of survivors for developing subsequent melanomas, monthly self-exams are strongly recommended as part of follow-up care. Yet, only a minority of high-risk individuals practices systematic and regular self-exams. This can be improved through patient education. However, dermatological education is effective only in about 50% of the cases and little is known about those who do not respond. In the current literature, psychosocial variables like distress, coping with cancer, as well as partner and physician support are widely neglected in relation to the practice of skin self-examination, despite the fact that they have been shown to be essential for other health behaviors and for adherence to medical advice. Moreover, the current body of knowledge is compromised by the inconsistent conceptualization of SSE. The main objective of the current project is to examine psychosocial predictors of skin self-examination using on a rigorous and clinically sound methodology.

Methods/Design

The longitudinal, mixed-method study examines key psychosocial variables related to the acquisition and to the long-term maintenance of skin self-examination in 200 patients with melanoma. Practice of self-exam behaviors is assessed at 3 and 12 months after receiving an educational intervention designed based on best-practice standards. Examined predictors of skin self-exam behaviors include biological sex, perceived self-exam efficacy, distress, partner and physician support, and coping strategies. Qualitative analyses of semi-structured interviews will complement and enlighten the quantitative findings.

Discussion

The identification of short and long-term predictors of skin self-examination and an increased understanding of barriers will allow health care professionals to better address patient difficulties in adhering to this life-saving health behavior. Furthermore, the findings will enable the development and evaluation of evidence-based, comprehensive intervention strategies. Ultimately, these findings could impact a wide range of outreach programs and secondary prevention initiatives for other populations with increased melanoma risk.
Literature
1.
Bleyer A, O’Leary M, Barr R, Ries LAG (Eds): NIH Pub. No. 06–5767 In Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975–2000. Bethesda, MD: National Cancer Institute; 2006.
2.
Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM: The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer 2000, 88: 2398–2424. 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-IPubMed
3.
Hausauer AK, Swetter SM, Cockburn MG, Clarke CA: Increases in melanoma among adolescent girls and young women in California: trends by socioeconomic status and UV radiation exposure. Arch Dermatol 2011,147(7):783–789. 10.1001/archdermatol.2011.44PubMed
4.
de Vries E, Bray FI, Coebergh JW, Parkin DM: Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003, 107: 119–126. 10.1002/ijc.11360PubMed
5.
Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A: SEER Cancer Statistics Review, 1975–2006. Bethesda, MD: National Cancer Institute; 2009.
6.
Safarians S, Sternlight MD, Freiman CJ, Huaman JA, Barsky SH: The primary tumor is the primary source of metastasis in a human melanoma/SCID model. Implications for the direct autocrine and paracrine epigenetic regulation of the metastatic process. Int J Canc 1996,66(2):151–158. 10.1002/(SICI)1097-0215(19960410)66:2<151::AID-IJC2>3.0.CO;2-1
7.
Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH, Glaser R: Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 2009,23(2):267–275. 10.1016/j.bbi.2008.10.005PubMed
8.
Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001, 19: 3635–3648.PubMed
9.
Berwick M, Erdei E, Hay J: Melanoma epidemiology and public health. Dermatol Clin 2009,27(2):205–214. 10.1016/j.det.2008.12.002PubMedPubMedCentral
10.
Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL: Malignant melanoma in the 21st century, part 1: Epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007, 82: 364–380.PubMed
11.
Rhodes AR: Cutaneous melanoma and intervention strategies to reduce tumor-related mortality: What we know, what we don't know, and what we think we know that isn't so. Dermatol Ther 2006, 19: 50–69. 10.1111/j.1529-8019.2005.00056.xPubMed
12.
Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL: Screening, early detection, and trends for melanoma: Current status (2000–2006) and future directions. J Am Acad Dermatol 2007, 57: 555–572. 10.1016/j.jaad.2007.06.032PubMed
13.
Burdern AD, Vestey JP, Srel M, Aitchison TC, Hunter JA, MacKie RM: Multiple primary melanoma: Risk factors and prognostic implications. Br Med J 1994, 309: 376.
14.
Uliasz A, Lebwohl M: Patient education and regular surveillance results in earlier diagnosis of second primary melanoma. Int J Dermatol 2007, 46: 575–577. 10.1111/j.1365-4632.2007.02704.xPubMed
15.
Ferrone CR, Ben Porat L, Panageas KS, Berwick M, Halpern AC, Patel A: Clinicopathological features of and risk factors for multiple primary melanomas. J Am Med Assoc 2005, 294: 1647–1654. 10.1001/jama.294.13.1647
16.
Kang S, Barnhill RL, Mihm MC, Sober AJ: Multiple primary cutaneous melanomas. Cancer 1992,70(7):1911–1916. 10.1002/1097-0142(19921001)70:7<1911::AID-CNCR2820700718>3.0.CO;2-QPubMed
17.
Manganoni AM, Farisoglio C, Tucci G, Facchetti F, Calzavara Pinton PG: The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: A report of 47 cases. J Eur Acad Dermatol Venereol 2007, 21: 1333–1336. 10.1111/j.1468-3083.2007.02263.xPubMed
18.
Stam-Posthuma JJ, Van Duinen C, Scheffer E, Vink J, Bergman W: Multiple primary melanoma. J Am Acad Dermatol 2001, 44: 22–27. 10.1067/mjd.2001.110878PubMed
19.
Garbe C, Paul A, Kohler-Spath H, Ellwanger U, Stroebel W, Schwarz M: Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: Recommendations for an effective follow-up strategy. J Clin Oncol 2003, 21: 520–529. 10.1200/JCO.2003.01.091PubMed
20.
Weinstock MA: Progress and prospects on melanoma: The way forward for early detection and reduced mortality. Clin Cancer Res 2006, 12: 2297–2300. 10.1158/1078-0432.CCR-05-2559
21.
Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C: Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005, 97: 195–199. 10.1093/jnci/dji019PubMed
22.
Cokkinides V, Weinstock M, Glanz K, Albano J, Ward E, Thun M: Trends in sunburns, sun protection practices, and attitudes toward sun exposure protection and tanning among US adolescents, 1998–2004. Pediatrics 2006, 118: 853–864. 10.1542/peds.2005-3109PubMed
23.
Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P: Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005, 41: 45–60. 10.1016/j.ejca.2004.10.016PubMed
24.
Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN: The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 2003, 120: 1087–1093. 10.1046/j.1523-1747.2003.12246.xPubMed
25.
Kasparian N, McLoone J, Meiser B: Skin cancer-related prevention and screening behaviors: a review of the literature. J Behav Med 2009,32(5):406–428. 10.1007/s10865-009-9219-2PubMed
26.
Brady MS, Oliveria SA, Christos PJ, Berwick M, Coit DG, Katz J: Patterns of detection in patients with cutaneous melanoma. Cancer 2000, 89: 342–347. 10.1002/1097-0142(20000715)89:2<342::AID-CNCR19>3.0.CO;2-PPubMed
27.
Carli P, De Giorgi V, Palli D, Maurichi A, Mulas P, Orlandi C: Dermatologist detection and skin self-examination are associated with thinner melanomas: Results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol 2003, 139: 607–612. 10.1001/archderm.139.5.607PubMed
28.
Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE: Is physician detection associated with thinner melanomas? J Am Med Assoc 1999, 281: 640–643. 10.1001/jama.281.7.640
29.
Schwartz JL, Wang TS, Hamilton TA, Lowe L, Sondak VK, Johnson TM: Thin primary melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer 2002, 95: 1562–1568. 10.1002/cncr.10880PubMed
30.
Körner A, Coroiu A, Martins C, Wang B: Predictors of skin self-examination before and after a melanoma diagnosis: The role of medical advice and patient’s level of education. Int Arch Med 2013, 6: 8. 10.1186/1755-7682-6-8PubMedPubMedCentral
31.
Schneider JS, Moore DH 2nd, Mendelsohn ML: Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J Am Acad Dermatol 2008, 58: 741–749. 10.1016/j.jaad.2007.10.648PubMed
32.
Aitken JF, Janda M, Elwood M, Youl PH, Ring IT, Lowe JB: Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J Am Acad Dermatol 2006, 54: 105–114. 10.1016/j.jaad.2005.08.072PubMed
33.
Aitken JF, Youl PH, Janda M, Lowe JB, Ring IT, Elwood M: Increase in skin cancer screening during a community-based randomized intervention trial. Int J Cancer 2006, 118: 1010–1016. 10.1002/ijc.21455PubMed
34.
Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL: Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996, 88: 17–23. 10.1093/jnci/88.1.17PubMed
35.
Dalal KM, Zhou Q, Panageas KS, Brady MS, Jaques DP, Coit DG: Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy. Ann Surg Oncol 2008, 15: 2206–2214. 10.1245/s10434-008-9985-z
36.
Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, DiMaio D, Guild V, Halpern AC: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Melanoma. J Natl Compr Canc Netw 2012,10(3):366–400.PubMed
37.
National Cancer Institute: What You Need To Know About™ Melanoma and Other Skin Cancers. Rockville, MD; 2010.
38.
39.
40.
Robinson JK, Fisher SG, Turrisi RJ: Predictors of skin self-examination performance. Cancer 2002, 95: 135–146. 10.1002/cncr.10637PubMed
41.
Geller AC, O'Riordan DL, Oliveria SA, Valvo S, Teich M, Halpern AC: Overcoming Obstacles to Skin Cancer Examinations and Prevention Counseling for High-Risk Patients: Results of a National Survey of Primary Care Physicians. J Am Board Fam Pract 2004,17(6):416–423. 10.3122/jabfm.17.6.416PubMed
42.
Robinson JK, Mallett KA, Turrisi R, Stapleton J, Robinson JK, Mallett KA, Turrisi R, Stapleton J: Engaging Patients and their Partners in Preventive Health Behaviors: The Physician Factor. Arch Dermatol 2009,145(4):469–473. 10.1001/archdermatol.2009.2PubMedPubMedCentral
43.
Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA: Who discovers melanoma? Patterns from a population-based survey. J Am Acad Dermatol 1992,26(6):914–919. 10.1016/0190-9622(92)70132-YPubMed
44.
Terushkin V, Halpern AC: Melanoma early detection. Hematol Oncol Clin North Am 2009,23(3):481–500. 10.1016/j.hoc.2009.03.001PubMed
45.
Manne S, Lessin S: Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. J Behav Med 2006, 29: 419–434. 10.1007/s10865-006-9064-5PubMed
46.
Mujumdar UJ, Hay JL, Monroe-Hinds YC, Hummer AJ, Begg CB, Wilcox HB, Oliveria SA, Berwick M: Sun protection and skin self-examination in melanoma survivors. Psychooncology 2009,18(10):1106–1115. 10.1002/pon.1510PubMedPubMedCentral
47.
DiFronzo LA, Wanek LA, Morton DL: Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up. Cancer 2001, 91: 1520–1524. 10.1002/1097-0142(20010415)91:8<1520::AID-CNCR1160>3.0.CO;2-6PubMed
48.
Friedman RJ, Rigel DS, Silverman MK, Kopf AW, Vossaert KA: Malignant melanoma in the 1990s: The continued importance of early detection and the role of physician examination and self-examination of the skin. Canc J Clin 1991,41(4):201–226. 10.3322/canjclin.41.4.201
49.
Azzarello LM, Dessureault S, Jacobsen PB: Sun-protective behavior among individuals with a family history of melanoma. Cancer Epidemiol Biomarkers Prev 2006,15(1):142–145. 10.1158/1055-9965.EPI-05-0478PubMed
50.
Robinson JK, Turrisi R, Stapleton J: Efficacy of a partner assistance intervention designed to increase skin self-examination performance. Arch Dermatol 2007, 143: 37–41. 10.1001/archderm.143.1.37PubMed
51.
Robinson JK, Stapleton J, Turrisi R: Relationship and partner moderator variables increase self-efficacy of performing skin self-examination. J Am Acad Dermatol 2008, 58: 755–762. 10.1016/j.jaad.2007.12.027PubMedPubMedCentral
52.
Robinson JK, Turrisi R, Stapleton J: Examination of mediating variables in a partner assistance intervention designed to increase performance of skin self-examination. J Am Acad Dermatol 2007, 56: 391–397. 10.1016/j.jaad.2006.10.028PubMed
53.
Körner A, Augustin M, Zschocke I: Health behaviors of skin cancer patients in melanoma follow-up care. Z Gesundh 2011,19(1):2–12. 10.1026/0943-8149/a000035
54.
Chiu V, Won E, Malik M, Weinstock MA: The use of mole-mapping diagrams to increase skin self-examination accuracy. J Am Acad Dermatol 2006,55(2):245–250. 10.1016/j.jaad.2006.02.026PubMed
55.
Robinson JK, Rigel DS, Amonette RA: What promotes skin self-examination? J Am Acad Dermatol 1998, 38: 752–757. 10.1016/S0190-9622(98)70204-XPubMed
56.
Berwick M, Oliveria S, Luo ST, Headley A, Bolognia JL: A pilot study using nurse education as an intervention to increase skin self-examination for melanoma. J Cancer Educ 2000, 15: 38–40.PubMed
57.
Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC: Patient adherence to skin self-examination effect on nurse intervention with photographs. Am J Prev Med 2004, 26: 152–155. 10.1016/j.amepre.2003.10.006PubMed
58.
Weinstock MA, Risica PM, Martin RA, Rakowski W, Smith KJ, Berwick M: Reliability of assessment and circumstances of performance of thorough skin self-examination for the early detection of melanoma in the Check-It-Out Project. Prev Med 2004, 38: 761–765. 10.1016/j.ypmed.2004.01.020PubMed
59.
Hamidi R, Peng D, Cockburn M: Efficacy of skin self-examination for the early detection of melanoma. Int J Dermatol 2010,49(2):126–134. 10.1111/j.1365-4632.2009.04268.xPubMed
60.
Kasparian NA, Branstrom R, Chang YM, Affleck P, Aspinwall LG, Tibben A, Azizi E, Baron-Epel O, Battistuzzi L, Bruno W: Skin examination behavior: The role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination. Arch Dermatol 2012,148(10):1–10.
61.
McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF: Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol 2006,54(5):783–792. 10.1016/j.jaad.2005.08.065PubMed
62.
DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW: Patient adherence and medical treatment outcomes: A meta-analysis. Med Care 2002,40(9):794–811. 10.1097/00005650-200209000-00009PubMed
63.
DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160: 2101–2107. 10.1001/archinte.160.14.2101PubMed
64.
Hay JL, Buckley TR, Ostroff JS: The role of cancer worry in cancer screening: A theoretical and empirical review of the literature. Psychooncology 2005,14(7):517–534. 10.1002/pon.864PubMed
65.
Hay JL, Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Halpern AC: Psychosocial mediators of a nurse intervention to increase skin self-examination in patients at high risk for melanoma. Canc Epidemiol Biomarkers Prev 2006, 15: 1212–1216. 10.1158/1055-9965.EPI-04-0822
66.
Zschocke I, Rhein J, Grimme H, Stein B, Muthny FA, Augustin M: Self-examination of patients with malignant melanoma in the aftercare: Relevance of psychosocial factors and instructions by the physicians. Dermatol Psychosom 2000, 1: 8–14. 10.1159/000057992
67.
Roberts N, Czajkowska Z, Radiotis G, Körner A: Distress and coping strategies among patients with skin cancer. J Clin Psychol Med Settings 2012,  . 10.1007/s10880-012-9319-y
68.
Hamama-Raz Y, Solomon Z, Schachter J, Azizi E: Objective and subjective stressors and the psychological adjustment of melanoma survivors. Psychooncology 2007, 16: 287–294. 10.1002/pon.1055PubMed
69.
Sollner W, Zschocke I, Zingg-Schir M, Stein B, Rumpold G, Fritsch P, Augustin M: Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness. Psychosomatics 1999,40(3):239–250. 10.1016/S0033-3182(99)71241-7PubMed
70.
Temoshok L: Malignant melanoma, AIDS, and the complex search for psychosocial mechanisms. Advances 1991, 7: 20–28.
71.
Kneier AW: The psychological challenges facing melanoma patients. Surg Clin North Am 1996,76(6):1413–1421. 10.1016/S0039-6109(05)70523-5PubMed
72.
Kneier AW, Temoshok L: Repressive coping reactions in patients with malignant melanoma as compared to cardiovascular disease patients. J Psychosom Res 1984,28(2):145–155. 10.1016/0022-3999(84)90008-4PubMed
73.
Lichtenthal W, Cruess DG, Schuchter LM, Ming ME: Psychosocial factors related to the correspondence of recipient and provider perceptions of social support among patients diagnosed with or at risk for malignant melanoma. J Health Psychol 2003,8(6):705–719. 10.1177/13591053030086005PubMed
74.
Dirksen S: Perceived well-being in malignant melanoma survivors. Oncol Nurs Forum 1989,16(3):353–358.PubMed
75.
Kasparian NA, McLoone JK, Butow PN: Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 2009,145(12):1415–1427. 10.1001/archdermatol.2009.308PubMed
76.
Glanz K, Lewis FM, Rimer BK: Health behavior and health education: Theory, research, and practice. 4th edition. San Francisco, CA: Jossey-Bass; 2008.
77.
Cancer Registry - McGill University Health Centre: Prevalence of cutaneous melanoma at the McGill University Health Centre in 2000–2007. Montreal, QC: McGill University Health Centre; 2009.
78.
Prevalence of cutaneous melanoma at the Jewish General Hospital in 2005–2007: Title. Thesis Type. Jewish General Hospital: University; 2008.
79.
Khanna M, Fortier-Riberdy G, Smoller B, Dinehart SM: Reporting tumor thickness for cutaneous squamous cell carcinoma. J Cutan Pathol 2002, 29: 321–323. 10.1034/j.1600-0560.2002.290601.xPubMed
80.
Lebel S, Jakubovits G, Rosberger Z, Loiselle C, Seguin C, Cornaz C, Ingram J, August L, Lisbona A: Waiting for a breast biopsy. Psychosocial consequences and coping strategies. J Psychosom Res 2003,55(5):437–443. 10.1016/S0022-3999(03)00512-9PubMed
81.
Couper JWBS, Love A, Duchesne G, Macvean M, Kissane DW: The psychosocial impact of prostate cancer on patients and their partners. Med J Aust 2006,185(8):428–432.PubMed
82.
Hersch J, Juraskova I, Price M, Mullan B: Psychosocial interventions and quality of life in gynaecological cancer patients: A systematic review. Psychooncology 2009, 18: 795–810. 10.1002/pon.1443PubMed
83.
Dale HLAP, Humphris GM: Systematic review of post-treatment psychosocial and behaviour change interventions for men with cancer. Psychooncology 2010, 19: 227–237. 10.1002/pon.1598PubMed
84.
Schou I, Ekeberg O, Karesen R, Sorensen E: Psychosocial intervention as a component of routine breast cancer care—who participates and does it help? Psychooncology 2008,17(7):716–720. 10.1002/pon.1264PubMed
85.
Lebel S, Rosberger Z, Edgar L, Devins GM: Predicting stress-related problems in long-term breast cancer survivors. J Psychosom Res 2008, 65: 513–523. 10.1016/j.jpsychores.2008.07.018PubMed
86.
Moadel AB, Shah C, Wylie-Rosett J, Harris MS, Patel SR, Hall CB, Sparano JA: Randomized Controlled Trial of Yoga Among a Multiethnic Sample of Breast Cancer Patients: Effects on Quality of Life. J Clin Oncol 2007,25(28):4387–4395. 10.1200/JCO.2006.06.6027PubMed
87.
Antoni MH, Wimberly SR, Lechner SC, Kazi A, Sifre T, Urcuyo KR, Phillips K, Smith RG, Petronis VM, Guellati S: Reduction of Cancer-Specific Thought Intrusions and Anxiety Symptoms With a Stress Management Intervention Among Women Undergoing Treatment for Breast Cancer. Am J Psychiatry 2006,163(10):1791–1797. 10.1176/appi.ajp.163.10.1791PubMed
88.
McCorkle R, Dowd M, Ercolano E, Schulman-Green D, Williams A, Siefert ML, Steiner J, Schwartz P: Effects of a nursing intervention on quality of life outcomes in post-surgical women with gynecological cancers. Psychooncology 2009,18(1):62–70. 10.1002/pon.1365PubMedPubMedCentral
89.
Manne SL, Rubin S, Edelson M, Rosenblum N, Bergman C, Hernandez E, Carlson J, Rocereto T, Winkel G: Coping and Communication-Enhancing Intervention Versus Supportive Counseling for Women Diagnosed With Gynecological Cancers. J Consult Clin Psychol 2007,75(4):615–628.PubMed
90.
Velji K: Effect of an individualized symptom education program on the symptom distress of women receiving radiation therapy for gynecological cancers. Toronto: University of Toronto; 2006.
91.
Nolte S, Donnelly J, Kelly S, Conley P, Cobb R: A randomized clinical trial of a videotape intervention for women with chemotherapy-induced alopecia: a gynecologic oncology group study. Oncol Nurs Forum 2006,33(2):305–311. 10.1188/06.ONF.305-311PubMed
92.
Chan YM, Lee PWH, Fong DYT, Fung ASM, Wu LYF, Choi AYY, Ng TY, Ngan HYS, Wong LC: Effect of Individual Psychological Intervention in Chinese Women With Gynecologic Malignancy: A Randomized Controlled Trial. J Clin Oncol 2005,23(22):4913–4924. 10.1200/JCO.2005.02.069PubMed
93.
Geller AC, Emmons KM, Brooks DR, Powers C, Zhang Z, Koh HK, Heeren T, Sober AJ, Li F, Gilchrest BA: A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer 2006,107(4):806–814. 10.1002/cncr.22050PubMed
94.
Andersen BL: Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol 2002,70(3):590–610.PubMedPubMedCentral
95.
Centre for Reviews and Dissemination CRD Report 30. In The effects of psychosocial interventions in cancer and heart disease: a review of systematic reviews. York: University of York; 2005.
96.
Lostumbo L, Carbine N, Wallace J, Ezzo J: Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 2010, CD002748.
97.
Nezu AM, Nezu CM, Felgoise SH, McClure KS, Houts PS, Nezu AM, Nezu CM, Felgoise SH, McClure KS, Houts PS: Project Genesis: assessing the efficacy of problem-solving therapy for distressed adult cancer patients. J Consult Clin Psychol 2003,71(6):1036–1048.PubMed
98.
Boone SL, Stapleton J, Turrisi R, Ortiz S, Robinson JK, Mallett KA, Boone SL, Stapleton J, Turrisi R, Ortiz S: Thoroughness of skin examination by melanoma patients: influence of age, sex and partner. Australas J Dermatol 2009,50(3):176–180. 10.1111/j.1440-0960.2009.00533.xPubMedPubMedCentral
99.
Blum A, Brand CU, Ellwanger U, Schlagenhauff W, Stroebel W, Rassner G: Awareness and early detection of cutaneous melanoma: An analysis of factors related to delay in treatment. Br J Dermatol 1999, 141: 783–787. 10.1046/j.1365-2133.1999.03196.xPubMed
100.
Francken A, Thompson JF, Bastiaannet E, Hoekstra HJ: Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up. Ned Tijdschr Geneeskd 2008, 152: 557–562.PubMed
101.
Carli P, DeGiorgi V, Chiarugi A, Stante M, Giannotti B: Multiple synchronous cutaneous melanomas: implications for prevention. Int J Dermatol 2002,41(9):583–585. 10.1046/j.1365-4362.2002.01605.xPubMed
102.
Goggins WB, Tsao H: A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer 2003, 97: 639–643. 10.1002/cncr.11116PubMed
103.
Walter FM, Humphrys E, Tso S, Johnson M, Cohn S: Patient understanding of moles and skin cancer, and factors influencing presentation in primary care: a qualitative study. BMC Fam Pract 2010,11(62):1471–2296.
104.
Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF: Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol 2007, 14: 1924–1933. 10.1245/s10434-007-9347-2PubMed
105.
Melanoma Network of Canada: About melanoma: Detection & Prevention.
106.
Murchie P, Hannaford PC, Wyke S, Nicolson MC, Campbell NC: Designing an integrated follow-up programme for people treated for cutaneous malignant melanoma: A practical application of the MRC framework for the design and evaluation of complex interventions to improve health. Fam Pract 2007, 24: 283–292. 10.1093/fampra/cmm006PubMed
107.
Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U: Evidence and interdisciplinary consensus-based German guidelines: Diagnosis and surveillance of melanoma. Melanoma Res 2007,17(6):393–399. 10.1097/CMR.0b013e3282f05039PubMed
108.
109.
110.
Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, Kopf AW, Polsky D: Early diagnosis of cutaneous melanoma: Revisiting the ABCD criteria. J Am Med Assoc 2004, 292: 2771–2776. 10.1001/jama.292.22.2771
111.
Canadian Dermatology Association: The ABCDEs of Malignant Melanoma. 2008.
112.
Rigel DS, Russak J, Friedman R: The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs. Canc J Clin 2010,60(5):301–316. 10.3322/caac.20074
113.
Rigel DS, Friedman RJ, Kopf AW, Polsky D: ABCDE - an evolving concept in the early detection of melanoma. Arch Dermatol 2005, 141: 1032–1034. 10.1001/archderm.141.8.1032PubMed
114.
Canadian Dermatology Association: Brochure - Malignant Melanoma. Public education material. Ottawa, ON; 2008.
115.
La Roche-Posay Laboratoire Dermatologique: Before showing it to the sun, show it to a dermatologist. Patient Education Material. Montreal, QC; 2012.
116.
Körner A: Skin Self-Examination Journal. Unpublished patient education material. QC, Montreal: McGill University, Department of Educational and Counselling Psychology; 2011.
117.
Moumne S, Czajkowska Z, Wang B, Khanna M, Körner A: The body map diary: Research tool and means for secondary prevention of melanoma. In Poster presented at the Annual conference of the Canadian Association of Psychosocial Oncology (CAPO): May 2011; Toronto, Canada. : ; 2011.
118.
Groleau D, Young A, Kirmayer LJ: The McGill Illness Narrative Interview (MINI): an interview schedule to elicits meanings and modes of reasoning related to illness experience. Transcult Psychiatry 2006,43(4):671–691. 10.1177/1363461506070796PubMed
119.
Miller DR, Geller AC, Wyatt SW, Halpern A, Howell JB, Cockerell C, Reilley BA, Bewerse BA, Rigel D, Rosenthal L, Amonette R, Sun T, Grossbart T, Lew RA, Koh HK: Melanoma awareness and self-examination practices: results of a United States survey. J Am Acad Dermatol 1996,34(6):962–970. 10.1016/S0190-9622(96)90273-XPubMed
120.
Geller AC: Educational and screening campaigns to reduce deaths from melanoma. Hematol Oncol Clin North Am 2009,23(3):515–527. 10.1016/j.hoc.2009.03.008PubMed
121.
Swetter S, Johnson T, Miller D, Layton C, Brooks K, Geller A: Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Arch Dermatol 2009,145(4):397–404. 10.1001/archdermatol.2008.603PubMed
122.
Körner A Ethics application for pilot study no. 10–126-PSY. In Adherence to medical advice - Understanding barriers and facilitators of skin self- examination in patients with melanoma. Montreal, QC: McGill University Health Centre; 2010.
123.
Weinstock MA, Risica PM, Martin RA, Rakowski W, Dube C, Berwick M: Melanoma early detection with thorough skin self-examination: The "Check It Out" randomized trial. Am J Prev Med 2007, 32: 517–524. 10.1016/j.amepre.2007.02.024PubMedPubMedCentral
124.
Körner A Research protocol no. A00-B39–11B approved by the Institutional Review Board. In Reducing Melanoma-Related Mortality in High Risk Individuals: Barriers and Facilitators of Adherence to Skin Self-Examination. Montreal, QC: Faculty of Medicine, McGill University; 2011.
125.
Schulz U, Schwarzer R: Long-term effects of spousal support on coping with cancer after surgery. J Soc Clin Psychol 2004,23(5):716–732. 10.1521/jscp.23.5.716.50746
126.
Matthews BA, Rhee JS, Neuburg M, Burzynski ML, Nattinger AB: Development of the facial skin care index: a health-related outcome index for skin cancer patients. Dermatol Surg 2006,32(7):924–934. 10.1111/j.1524-4725.2006.32197.xPubMedPubMedCentral
127.
Rhee J, Matthews B, Neuburg M, Logan B, Burzynski M, Nattinger A: The skin cancer index: clinical responsiveness and predictors of quality of life. Laryngoscope 2007,117(3):399–405. 10.1097/MLG.0b013e31802e2d88PubMedPubMedCentral
128.
Kroenke K, Spitzer RL, Williams JB, Lowe B: The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: A systematic review. Gen Hosp Psychiatry 2010,32(4):345–359. 10.1016/j.genhosppsych.2010.03.006PubMed
129.
Carver CS, Scheier MF, Weintraub JK: Assessing Coping Strategies - a Theoretically Based Approach. J Pers Soc Psychol 1989,56(2):267–283.PubMed
130.
Canadian Dermatology Association: A Guide to Skin Cancer Self-Examination. Ottawa, ON; 2008.
131.
Hill CE, Thompson BJ, Williams EN: A guide to conducting consensual qualitative research. Counsel Psychol 1997,25(4):517–572. 10.1177/0011000097254001
132.
Hill C, Knox S, Thompson B, Nutt EW, Hess SA: Consensual qualitative research: An update. Counsel Psychol 2005, 52: 162–205.
133.
Paulus T, Woodside M, Ziegler M: Extending the conversation: Qualitative research as dialogic collaborative process. Qual Rep 2008, 13: 226–243.
134.
Strauss A, Corbin J: Basics of qualitative research: Techniques and procedures for developing grounded theory. 2nd edition. Thousand Oaks, CA: Sage; 1998.
Metadata
Title
Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care
Authors
Annett Körner
Martin Drapeau
Brett D Thombs
Zeev Rosberger
Beatrice Wang
Manish Khanna
Alan Spatz
Adina Coroiu
Rosalind Garland
Gerald Batist
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Dermatology / Issue 1/2013
Electronic ISSN: 1471-5945
DOI
https://doi.org/10.1186/1471-5945-13-3

Other articles of this Issue 1/2013

BMC Dermatology 1/2013 Go to the issue

Research article

Single application of 4% dimeticone liquid gel versus two applications of 1% permethrin creme rinse for treatment of head louse infestation: a randomised controlled trial

Reviewer acknowledgement

BMC Dermatology reviewer acknowledgement, 2012

Research article

Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa

Research article

TGFβ signaling regulates lipogenesis in human sebaceous glands cells

Research article

Longitudinal, mixed method study to look at the experiences and knowledge of non melanoma skin cancer from diagnosis to one year

Research article

Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme